Novel E2F decoy oligodeoxynucleotides inhibit in vitro vascular smooth muscle cell proliferation and in vivo neointimal hyperplasia.
about
Neointimal hyperplasia associated with synthetic hemodialysis grafts.Aldose reductase regulates vascular smooth muscle cell proliferation by modulating G1/S phase transition of cell cycle.Inhibition of aldose reductase prevents growth factor-induced G1-S phase transition through the AKT/phosphoinositide 3-kinase/E2F-1 pathway in human colon cancer cellsInhibitory effect of ribbon-type NF-kappaB decoy oligodeoxynucleotides on osteoclast induction and activity in vitro and in vivoSmall-nucleic-acid-based therapeutic strategy targeting the transcription factors regulating the vascular inflammation, remodeling and fibrosis in atherosclerosisSubcellular localization as a limiting factor for utilization of decoy oligonucleotides.Synthesis and characterization of oligodeoxynucleotides containing naphthyridine:imidazopyridopyrimidine base pairs at their sticky ends. Application as thermally stabilized decoy molecules.Ascochlorin inhibits matrix metalloproteinase-9 expression by suppressing activator protein-1-mediated gene expression through the ERK1/2 signaling pathway: inhibitory effects of ascochlorin on the invasion of renal carcinoma cells.Systemic administration of ribbon-type decoy oligodeoxynucleotide against nuclear factor κB and ets prevents abdominal aortic aneurysm in rat modelTranscription factor decoy for AP-1 reduces mesangial cell proliferation and extracellular matrix production in vitro and in vivo.Liver-directed gene therapy of diabetic rats using an HVJ-E vector containing EBV plasmids expressing insulin and GLUT 2 transporter.A critical role of E2F transcription factor 2 in proinflammatory cytokines-dependent proliferation and invasiveness of fibroblast-like synoviocytes in rheumatoid Arthritis.
P2860
Q30492883-F4D84903-695C-47FB-9155-19D9940093F5Q33848283-48AE2DB3-CB80-4B22-AA79-A971BBE75ED1Q34159639-5B35E933-5E24-4427-8A41-636A7E130704Q35605522-65BC5844-DBE4-4A21-8D7E-E0CF9D993A31Q35723980-2F0A1245-BA08-4A70-8ACC-B75C2B862CD4Q37619688-24D002B8-7CC7-4DB3-B1A5-1F6EBAB43DFEQ38308687-50AB2FD4-AB4A-4628-8A06-D05D9DA03C7FQ40428673-C935CC72-5D52-4072-8052-FEB5DDD8CA51Q41681789-3F9FE8AB-7ED7-43AB-91DF-218B8ECC4780Q44762884-3BF60AE4-DD70-48FA-8E44-A1D985CB575BQ45887123-0E8CA173-7E5F-4053-BDAB-A099BC4389D7Q49410209-38530567-2D99-4ACE-994F-283D25263FD5
P2860
Novel E2F decoy oligodeoxynucleotides inhibit in vitro vascular smooth muscle cell proliferation and in vivo neointimal hyperplasia.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Novel E2F decoy oligodeoxynucl ...... n vivo neointimal hyperplasia.
@en
Novel E2F decoy oligodeoxynucl ...... n vivo neointimal hyperplasia.
@nl
type
label
Novel E2F decoy oligodeoxynucl ...... n vivo neointimal hyperplasia.
@en
Novel E2F decoy oligodeoxynucl ...... n vivo neointimal hyperplasia.
@nl
prefLabel
Novel E2F decoy oligodeoxynucl ...... n vivo neointimal hyperplasia.
@en
Novel E2F decoy oligodeoxynucl ...... n vivo neointimal hyperplasia.
@nl
P2093
P2860
P356
P1433
P1476
Novel E2F decoy oligodeoxynucl ...... n vivo neointimal hyperplasia.
@en
P2093
Morishita R
P2860
P2888
P304
P356
10.1038/SJ.GT.3301849
P577
2002-12-01T00:00:00Z